Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 52
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018 | Chambers C, Hickman R, Sabaiduc S, Chan T, Jassem A, Rose C, Krajden M, Skowronski DM, Petric M, De Serres G, Martineau C, Charest H, Winter A-L, Gubbay JB, Dickinson JA, Fonseca K, Drews SJ, Bastien N, Li Y | 2018 | Clin Infect Dis | View Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018 | Researchers | Clinical research |
Les immunoglobulines | Harding RS, Lazarus A | 2018 | Guide de la pratique transfusionnelle | View Les immunoglobulines | Health care providers | Other |
Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Kim K, Tarr GAM, Chui L, Drews S, Pang X-L, Lee BE, Ali S, Nettel-Aguirre A, Vanderkooi OG, Berenger BM, Dickinson J, Tarr PI, MacDonald J, Freedman SB | 2018 | Clin Infect Dis | View Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Health care providers | Clinical research |
Severe autoimmune LMWH-induced thrombocytopenia presenting with aortic thromboses, adrenal hemorrhage and pulmonary embolism: response to high-dose intravenous immunoglobulin | Nero J, Araneta P, Warkentin T, Moodley O | 2018 | Can J Gen Intern Med | View Severe autoimmune LMWH-induced thrombocytopenia presenting with aortic thromboses, adrenal hemorrhage and pulmonary embolism: response to high-dose intravenous immunoglobulin | Health care providers | Clinical research |
Concentrés pour les troubles de l'hémostase et l'angioedéme héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Concentrés pour les troubles de l'hémostase et l'angioedéme héréditaire | Health care providers | Benchmarking and standard setting |
Bacterial neuraminidase-mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure | Qadri SM, Donkor DA, Nazy I, Branch DR, Sheffield WP | 2018 | Eur J Haematol | View Bacterial neuraminidase-mediated erythrocyte desialylation provokes cell surface aminophospholipid exposure | Researchers | Basic research |
Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets | Quach ME, Dragovich MA, Chen W, Syed AK, Cao W, Liang X, Deng W, De Meyer SF, Zhu G, Peng J, Ni H, Bennett CM, Hou M, Ware J, Deckmyn H, Zhang XF, Li R | 2018 | Blood | View Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets | Researchers | Basic research |
Improved resolution in extracellular vesicle populations using 405 instead of 488Â nm side scatter | McVey MJ, Spring CM, Kuebler WM | 2018 | J Extracell Vesicles | View Improved resolution in extracellular vesicle populations using 405 instead of 488Â nm side scatter | Researchers | Basic research |
Cardiac stress biomarkers after red blood cell transfusion in patients at risk for transfusion-associated circulatory overload: a prospective observational study | Callum JL, Cohen R, Cressman AM, Strauss R, Armali C, Lin Y, Pendergrast J, Lieberman L, Scales DC, Skeate R, Ross H, Cserti-Gazdewich C | 2018 | Transfusion | View Cardiac stress biomarkers after red blood cell transfusion in patients at risk for transfusion-associated circulatory overload: a prospective observational study | Researchers | Clinical research |
Moving from a permanent to a 5 year deferral for donors with cured cancer results in a substantial reduction in deferral rates | Goldman M, Yi Q-L, O'Brien SF | 2018 | ISBT Sci Ser | View Moving from a permanent to a 5 year deferral for donors with cured cancer results in a substantial reduction in deferral rates | Blood operators | New or improved product or process |
Electronic patient identification for sample labeling reduces wrong blood in tube errors | Kaufman RM, Dinh A, Cohn CS, Fung MK, Gorlin J, Melanson S, Murphy MF, Ziman A, Elahie AL, Chasse D, Degree L, Dunbar NM, Dzik WH, Flanagan P, Gabert K, Ipe TS, Jackson B, Lane D, Raspollini E, Ray C, Sharon Y, Ellis M, Selleng K, Staves J, Yu P, Zeller M, Yazer M, BEST Collaborative | 2018 | Transfusion | View Electronic patient identification for sample labeling reduces wrong blood in tube errors | Researchers | Clinical research |
Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Strauss R, Downie H, Wilson A, Mounchili A, Berry B, Cserti-Gazdewich C, Callum J | 2018 | Transfusion | View Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Health care providers | Clinical research |
Platelet transfusion, alloimmunization, and management of platelet refractoriness | Zeller M, Petraszko T | 2018 | Clinical Guide to Transfusion | View Platelet transfusion, alloimmunization, and management of platelet refractoriness | Health care providers | Other |
Closing in on DEHP-free red blood cell concentrate containers | Almizraq RJ, Acker J | 2018 | Transfusion | View Closing in on DEHP-free red blood cell concentrate containers | Researchers | New or improved product or process |
Albumine | Clarke G, Yan M | 2018 | Guide de la pratique transfusionnelle | View Albumine | Health care providers | Other |
Risk-based decision making in transfusion medicine | Leach Bennett J, Devine DV | 2018 | Vox Sang | View Risk-based decision making in transfusion medicine | Researchers | New or improved product or process |
Human T-cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada | O'Brien SF, Yi Q-L, Goldman M, Grégoire Y, Delage G | 2018 | Vox Sang | View Human T-cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada | Researchers | New or improved product or process |
Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review | Rash JA, Buckley N, Busse JW, Campbell TS, Corace K, Cooper L, Flusk D, Iorio A, Lavoie KL, Poulin PA, Skidmore B | 2018 | Systematic Reviews | View Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review | Researchers | Clinical research |
Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents | Xu XR, Yousef GM, Ni H | 2018 | Blood | View Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents | Health care providers | Clinical research |
Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence | Fingrut W, Rikhraj K, Allan D | 2018 | Vox Sang | View Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence | Blood operators | Clinical research |
Concentré de recherche: Où l'on optimise un test de laboratoire pour déterminer la compatibilité entre donneurs et receveurs | Acker J, Branch D | 2018 | Blood.ca website | View Concentré de recherche: Où l'on optimise un test de laboratoire pour déterminer la compatibilité entre donneurs et receveurs | Other | Other |
Anti-M | Clarke G, Cote J, Lane D | 2018 | Blood.ca website | View Anti-M | Researchers | Basic research |
International validation of harmonized definitions for complications of blood donations | Land KJ, Townsend M, Goldman M, Whitaker BI, Perez GE, Wiersum-Osselton JC | 2018 | Transfusion | View International validation of harmonized definitions for complications of blood donations | Blood operators | New or improved product or process |
Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Wan H, Wang Y, Ai J, Brathwaite S, Ni H, Macdonald RL, Hol EM, Meijers JCM, Vergouwen MDI | 2018 | J Thromb Haemost | View Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Researchers | Basic research |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Jenkins C | 2018 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls | Mannucci PM, Nobili A, Marchesini E, Oliovecchio E, Cortesi L, Coppola A, Santagostino E, Radossi P, Castaman G, Valdrè L, Santoro C, Tagliaferri A, Ettorre C, Zanon E, Barillari G, Cantori I, Caimi TM, Sottilotta G, Peyvandi F, Iorio A | 2018 | Haemophilia | View Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls | Health care providers | Clinical research |
Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review | Siegal DM, Manning N, Jackson Chornenki NL, Hillis CM, Heddle NM | 2018 | J Intensive Care Med | View Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review | Researchers | New or improved product or process |
Window to the Unknown: Using Storytelling to Identify Learning Needs for the Intrinsic Competencies Within an Online Needs Assessment | Tseng EK, Jo D, Shih AW, De Wit K, Chan TM | 2018 | AEM Educ Train | View Window to the Unknown: Using Storytelling to Identify Learning Needs for the Intrinsic Competencies Within an Online Needs Assessment | Researchers | Education research |
Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia | Nazy I, Kelton JG, Moore JC, Clare R, Horsewood P, Smith JW, Ivetic N, D'Souza V, Li N, Arnold DM | 2018 | Br J Haematol | View Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia | Health care providers | Clinical research |
Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Health care providers | Benchmarking and standard setting |
Fusion to human serum albumin extends the circulatory half-life and duration of antithrombotic action of the Kunitz protease inhibitor domain of Protease Nexin 2 | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | Cell Physiol Biochem | View Fusion to human serum albumin extends the circulatory half-life and duration of antithrombotic action of the Kunitz protease inhibitor domain of Protease Nexin 2 | Researchers | Basic research |
Modeling rare blood in Canada | Blake JT, Clarke G | 2018 | Transfusion | View Modeling rare blood in Canada | Health care providers | New or improved product or process |
Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | de Souza LR, Scott BM, Bhakta V, Donkor DA, Perruzza DL, Sheffield WP | 2018 | Serpins: Methods and Protocols | View Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | Researchers | Other |
Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Health care providers | Benchmarking and standard setting |
Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Linkins L, Hu G, Warkentin TE | 2018 | Res Pract Thromb Haemost | View Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Researchers | Clinical research |
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | BMC Biotechnol | View A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Researchers | Basic research |
Red cell supernatant effects on endothelial cell function and innate immune activation is influenced by donor age and sex | Kipkeu BJ, Almizraq R, Branch DR, Acker JP, Holovati JL | 2018 | ISBT Sci Ser | View Red cell supernatant effects on endothelial cell function and innate immune activation is influenced by donor age and sex | Researchers | Basic research |
ResearchUnit: Platelet protein GPIba plays an important role in regulating platelet-mediated production of thrombopoietin by the liver | Ni H | 2018 | Blood.ca website | View ResearchUnit: Platelet protein GPIba plays an important role in regulating platelet-mediated production of thrombopoietin by the liver | Other | Other |
Troubles de l'hémostase et angioedéme héréditaire | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Troubles de l'hémostase et angioedéme héréditaire | Health care providers | Other |
Anti-D; a type of IVIg | Khan R, Lazarus A | 2018 | Antibody Therapy: Substitution - Immunomodulation - Monoclonal Immunotherapy | View Anti-D; a type of IVIg | Health care providers | Other |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Kavsak PA, Ainsworth C, Arnold DM, Scott T, Clark L, Ivica J, Mackett K, Whitlock R, Worster A | 2018 | Clin Biochem | View The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Researchers | Basic research |
Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Nagao M, Sengupta J, Diaz-Dussan D, Adam M, Wu M, Acker J, Ben R, Ishihara K, Zeng H, Miura Y, Narain R | 2018 | ACS Appl Bio Mater | View Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Researchers | Basic research |
Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use | Lin Y, Cohen R, Armali C, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J | 2018 | Vox Sang | View Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use | Researchers | Clinical research |
Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Almizraq RJ, Norris PJ, Inglis H, Menocha S, Wirtz MR, Juffermans N, Pandey S, Spinella PC, Acker JP, Muszynski JA | 2018 | Blood Adv | View Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Researchers | Basic research |
Albumin | Clarke G, Yan M | 2018 | Clinical Guide to Transfusion | View Albumin | Health care providers | Other |
McMaster RARE-Best practices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome | Legault K, Schunemann H, Hillis C, Yeung C, Akl EA, Carrier M, Cervera R, Crowther M, Dentali F, Erkan D, Espinosa G, Khamashta M, Meerpohl JJ, Moffat K, O'Brien S, Pengo V, Rand JH, Rodriguez Pinto I, Thom L, Iorio A | 2018 | J Thromb Haemost | View McMaster RARE-Best practices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome | Health care providers | Benchmarking and standard setting |
Designing the blood supply chain: how much, how and where? | Osorio AF, Brailsford SC, Smith HK, Blake J | 2018 | Vox Sang | View Designing the blood supply chain: how much, how and where? | Other | New or improved product or process |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
ResearchUnit: A model for change: predicting the impact of system-wide improvements | Blake J | 2018 | Blood.ca website | View ResearchUnit: A model for change: predicting the impact of system-wide improvements | Other | New or improved product or process |